Canaccord Genuity analyst Jason Mills maintained a Hold rating on Angiodynamics (NASDAQ: ANGO) today and set a price target of $20. The company’s shares opened today at $18.95.
According to TipRanks.com, Mills is a top 25 analyst with an average return of 30.9% and a 76.5% success rate. Mills covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Boston Scientific Corp, and Staar Surgical Company.
The word on The Street in general, suggests a Hold analyst consensus rating for Angiodynamics.
See today’s analyst top recommended stocks >>
The company has a one-year high of $23.95 and a one-year low of $14.97. Currently, Angiodynamics has an average volume of 199.4K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
AngioDynamics, Inc. engages in the business of medical devices. Its activities include design, manufactures, and sale of medical, surgical and diagnostic devices. The company focuses on devices in the field of vascular access, peripheral vascular, oncology, and surgery.
